On September 23 and 24, Axinn partners Aziz Burgy and Stacie Ropka will speak at the ACI Summit on Biosimilars & Innovator Biologics Virtual Conference.
On September 23, Aziz will speak on a panel entitled, "The Economics of Biosimilars: Considerations for Market Access, Sustainable Pricing and Reimbursement Policies." This panel will analyze the California legislation aimed at ending pay-for-delay in pharmaceutical patent infringement settlements. Speakers will also review the implications of the House passed Lower Drug Costs Now Act.
On September 24, Stacie will speak on a panel entitled, "In-House Town Hall: An Insider’s Guide to What In-House Counsel Expect from Law Firm Counterparts." This panel will review the impact of COVID-19 on global biosimilars market trends and analyze whether manufacturers pursue interchangeability designations for products.
Click here for more information, including how to register.